IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

News

Clara Campàs, founding partner of Asabys Partners, Salvador Aznar-Benitah and Valerie Vanhooren, founders of Ona Therapeutics, and Sergio Pérez, director of Sabadell Venture Capital
Innovation
The IRB Barcelona spin-off Ona Therapeutics hits the road thanks to Sabadell Asabys
Antonio Zorzano and his team at the Complex Metabolic Diseases and Mitochondria Lab have participated in this study. IRB Barcelona.
Scientific
Researchers at IRB Barcelona identify a protein that protects against non-alcoholic fatty liver disease
Structure of EGFR. Purple indicates the region recognised by mAB806. Laura Orellana.
Scientific
Researchers discover the mechanism of action of an antitumour drug used for the treatment of glioblastoma
Francesc Posas, director of IRB Barcelona.
Institutional
Francesc Posas and Modesto Orozco receive the 2018 ICREA Academia Award
Structure of the BasC transporter. Manuel Palacín, IRB Barcelona.
Scientific
Characterisation of the structure and function of a member of the L-Amino acid Transporter (LAT) family
Different localization of the proteins involved in apoptosis in basal (Ctrl) and upon death receptor induction with TRAIL. Saška Ivanova, IRB Barcelona
Scientific - Published in EMBO Journal
Researchers identify a new biomarker for personalised treatments against cancer
Institutional
Know the development of cancer through the fruit fly
Press conference at IRB Barcelona, presenting the #MetastasisChallenge
Institutional
IRB Barcelona calls society to action in the fight against metastasis
Starlife’s presentation at the Barcelona Supercomputing Center
Institutional
Launch of “StarLife”, a new informatics infrastructure to boost biomedical research

Media Mentions

Blog

Do you want to be informed?

Visit our blog.

IRB Blog